No Nod For Covaxin Yet, WHO Seeks "Additional Clarifications" | Read
PUBLISHED ON: October 27, 2021 | Duration: 1 min, 25 sec
The World Health Organisation's technical advisory group on Tuesday sought "additional clarifications" from Bharat Biotech for its COVID-19 vaccine Covaxin to conduct a final "risk-benefit assessment" for Emergency Use Listing of the vaccine.
